ATC codes:
A10AC01
Indication
Type 2 diabetes mellitus
ICD11 code:
5A11
INN
Neutral insulin injection
Medicine type
Biological agent
List type
Core
Additional notes
including quality-assured biosimilars
Formulations
Parenteral > General injections > SC:
40 IU per mL in 10 mL vial (soluble) ;
100 IU per mL in 10 mL vial (soluble) ;
100 IU per mL in 3 mL cartridge (soluble) ;
100 IU per mL in 3 mL pre-filled pen (soluble)
EML status history
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended that the current listings for human insulin on the core list of the EML and EMLc be extended to include cartridge and pre-filled pen delivery systems. The Committee considered that cartridges and pre-filled pens may offer advantages for patients over vials and syringes in terms of ease of use, greater accuracy of dosing and improved adherence. The Committee acknowledged that affordable access to insulin products remains a critical global health priority.